+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cervical Cancer Treatment Market Analysis & Trends - Industry Forecast to 2027

  • ID: 4747767
  • Report
  • January 2019
  • Region: Global
  • 188 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Allergan, Plc.
  • Biocon Ltd.
  • Eli Lilly And Company
  • Ethicon, Inc.
  • Genentech USA
  • GlaxoSmithKline
  • MORE
The Global Cervical Cancer Treatment Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include increasing R&D expenditure in oncologic diseases, improvement of systemic chemotherapy and rise in conservative treatment in early stage disease.

Based on Treatment, the market is divided into chemotherapy, hormone therapy, radiation therapy, surgery, targeted therapy, Loop Electrosurgical Excision Procedure (LEEP), cone biopsy and cold knife conization. Chemotherapy is sub divided into carboplatin, bevacizumab, paclitaxel, oxorubicin, cisplatin and other chemotherapies. Hormone Therapy is further segmented into progesterone, oestrogen, testosterone and progestogens. Radiation Therapy is sub segmented into brachytherapy and external beam radiation. Surgery is further divided into laser surgery, trachelectomy, radical hysterectomy, cryosurgery, simple hysterectomy and other surgeries. Targeted Therapy is divided into pazopanib and bevacizumab.

By Type, the market is segregated into Adenosquamous Carcinomas, Squamous Cell Carcinomas and Adenocarcinomas.

Based on Material, the market is fragmented into biologically derived materials, synthetic materials, genetically engineered materials and other materials.

By product, the market is segmented into Treatment and Prevention. Treatment is further segmented into keytruda, generics, avastin and other treatments. Prevention is sub divided into Cervarix and Gardasil/Gardasil 9.

Based on Disease Indication, the market is categorised into early invasive stage, advanced invasive stage and pre-malignant lesions.

Based on distribution channel, the market is classified into online pharmacies, hospital pharmacies and retail pharmacies.

Depending on end user, the market is segregated into diagnostic centers, pharmacies, cancer palliative care clinics and hospitals.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
Middle East
  • Saudi Arabia
  • UAE
  • Rest of Middle East
Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
Rest of the World
  • South Africa
  • Others
Report Highlights:
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Plc.
  • Biocon Ltd.
  • Eli Lilly And Company
  • Ethicon, Inc.
  • Genentech USA
  • GlaxoSmithKline
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 End User Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing R & D expenditure in Oncologic Diseases
3.1.2 Improvement of Systemic Chemotherapy
3.1.3 Rise in Conservative Treatment in Early Stage Disease
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Cervical Cancer Treatment Market, By Treatment
4.1 Chemotherapy
DATA TABLE Chemotherapy Market Forecast to 2027 (US$ MN)
4.1.1 Carboplatin
DATA TABLE Carboplatin Market Forecast to 2027 (US$ MN)
4.1.2 Bevacizumab
DATA TABLE Bevacizumab Market Forecast to 2027 (US$ MN)
4.1.3 Paclitaxel
DATA TABLE Paclitaxel Market Forecast to 2027 (US$ MN)
4.1.4 Oxorubicin
DATA TABLE Oxorubicin Market Forecast to 2027 (US$ MN)
4.1.5 Cisplatin
DATA TABLE Cisplatin Market Forecast to 2027 (US$ MN)
4.1.6 Other Chemotherapies
DATA TABLE Other Chemotherapies Market Forecast to 2027 (US$ MN)
4.2 Hormone Therapy
DATA TABLE Hormone Therapy Market Forecast to 2027 (US$ MN)
4.2.1 Progesterone
DATA TABLE Progesterone Market Forecast to 2027 (US$ MN)
4.2.2 Oestrogen
DATA TABLE Oestrogen Market Forecast to 2027 (US$ MN)
4.2.3 Testosterone
DATA TABLE Testosterone Market Forecast to 2027 (US$ MN)
4.2.4 Progestogens
DATA TABLE Progestogens Market Forecast to 2027 (US$ MN)
4.3 Radiation Therapy
DATA TABLE Radiation Therapy Market Forecast to 2027 (US$ MN)
4.3.1 Brachytherapy
DATA TABLE Brachytherapy Market Forecast to 2027 (US$ MN)
4.3.2 External Beam Radiation
DATA TABLE External Beam Radiation Market Forecast to 2027 (US$ MN)
4.4 Surgery
DATA TABLE Surgery Market Forecast to 2027 (US$ MN)
4.4.1 Laser Surgery
DATA TABLE Laser Surgery Market Forecast to 2027 (US$ MN)
4.4.2 Trachelectomy
DATA TABLE Trachelectomy Market Forecast to 2027 (US$ MN)
4.4.3 Radical Hysterectomy
DATA TABLE Radical Hysterectomy Market Forecast to 2027 (US$ MN)
4.4.4 Cryosurgery
DATA TABLE Cryosurgery Market Forecast to 2027 (US$ MN)
4.4.5 Simple Hysterectomy
DATA TABLE Simple Hysterectomy Market Forecast to 2027 (US$ MN)
4.4.6 Other Surgeries
DATA TABLE Other Surgeries Market Forecast to 2027 (US$ MN)
4.5 Targeted Therapy
DATA TABLE Targeted Therapy Market Forecast to 2027 (US$ MN)
4.5.1 Pazopanib
DATA TABLE Pazopanib Market Forecast to 2027 (US$ MN)
4.5.2 Bevacizumab
DATA TABLE Bevacizumab Market Forecast to 2027 (US$ MN)
4.6 Loop Electrosurgical Excision Procedure (LEEP)
DATA TABLE Loop Electrosurgical Excision Procedure (LEEP)
4.7 Cone Biopsy
DATA TABLE Cone Biopsy Market Forecast to 2027 (US$ MN)
4.8 Cold Knife Conization
DATA TABLE Cold Knife Conization Market Forecast to 2027 (US$ MN)

5 Cervical Cancer Treatment Market, By Type
5.1 Adenosquamous Carcinomas
DATA TABLE Adenosquamous Carcinomas Market Forecast to 2027 (US$ MN)
5.2 Squamous Cell Carcinomas
DATA TABLE Squamous Cell Carcinomas Market Forecast to 2027 (US$ MN)
5.3 Adenocarcinomas
DATA TABLE Adenocarcinomas Market Forecast to 2027 (US$ MN)

6 Cervical Cancer Treatment Market, By Material
6.1 Biologically Derived Materials
DATA TABLE Biologically Derived Materials Market Forecast to 2027 (US$ MN)
6.2 Synthetic Materials
DATA TABLE Synthetic Materials Market Forecast to 2027 (US$ MN)
6.3 Genetically Engineered Materials
DATA TABLE Genetically Engineered Materials Market Forecast to 2027 (US$ MN)
6.4 Other Materials
DATA TABLE Other Materials Market Forecast to 2027 (US$ MN)

7 Cervical Cancer Treatment Market, By Product
7.1 Treatment
DATA TABLE Treatment Market Forecast to 2027 (US$ MN)
7.1.1 Keytruda
DATA TABLE Keytruda Market Forecast to 2027 (US$ MN)
7.1.2 Generics
DATA TABLE Generics Market Forecast to 2027 (US$ MN)
7.1.3 Avastin
DATA TABLE Avastin Market Forecast to 2027 (US$ MN)
7.1.4 Other Treatments
DATA TABLE Other Treatments Market Forecast to 2027 (US$ MN)
7.2 Prevention
DATA TABLE Prevention Market Forecast to 2027 (US$ MN)
7.2.1 Cervarix
DATA TABLE Cervarix Market Forecast to 2027 (US$ MN)
7.2.2 Gardasil/Gardasil 9
DATA TABLE Gardasil/Gardasil 9 Market Forecast to 2027 (US$ MN)

8 Cervical Cancer Treatment Market, By Disease Indication
8.1 Early Invasive Stage
DATA TABLE Early Invasive Stage Market Forecast to 2027 (US$ MN)
8.2 Advanced Invasive Stage
DATA TABLE Advanced Invasive Stage Market Forecast to 2027 (US$ MN)
8.3 Pre-malignant lesions
DATA TABLE Pre-malignant lesions Market Forecast to 2027 (US$ MN)

9 Cervical Cancer Treatment Market, By Distribution Channel
9.1 Online Pharmacies
DATA TABLE Online Pharmacies Market Forecast to 2027 (US$ MN)
9.2 Hospital Pharmacies
DATA TABLE Hospital Pharmacies Market Forecast to 2027 (US$ MN)
9.3 Retail Pharmacies
DATA TABLE Retail Pharmacies Market Forecast to 2027 (US$ MN)

10 Cervical Cancer Treatment Market, By End User
10.1 Diagnostic Centers
DATA TABLE Diagnostic Centers Market Forecast to 20210 (US$ MN)
10.2 Pharmacies
DATA TABLE Pharmacies Market Forecast to 20210 (US$ MN)
10.3 Cancer Palliative care clinics
DATA TABLE Cancer Palliative care clinics Market Forecast to 20210 (US$ MN)
10.4 Hospitals
DATA TABLE Hospitals Market Forecast to 20210 (US$ MN)

11 Cervical Cancer Treatment Market, By Geography
11.1 North America
DATA TABLE North America Market Forecast by Countries to 2027 (US$ MN)
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
DATA TABLE Europe Market Forecast by Countries to 2027 (US$ MN)
11.2.1 Germany
11.2.2 U.K
11.2.3 Italy
11.2.4 France
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia Pacific
DATA TABLE Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 New Zealand
11.3.6 Rest of Asia Pacific
11.4 Middle East
DATA TABLE Middle East Market Forecast by Countries to 2027 (US$ MN)
11.4.1 Saudi Arabia
11.4.2 UAE
11.4.3 Rest of Middle East
11.5 Latin America
DATA TABLE Latin America Market Forecast by Countries to 2027 (US$ MN)
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Rest of Latin America
11.6 Rest of the World (RoW)
DATA TABLE RoW Market Forecast by Countries to 2027 (US$ MN)
11.6.1 South Africa
11.6.2 Others

12 Key Player Activities
12.1 Acquisitions & Mergers
12.2 Agreements, Partnerships, Collaborations and Joint Ventures
12.3 Product Launch & Expansions
12.4 Other Activities

13 Leading Companies
13.1 Pfizer Inc
13.2 Bristol-Myers Squibb Company
13.3 Novartis
13.4 Eli Lilly And Company
13.5 Allergan, Plc.
13.6 GlaxoSmithKline
13.7 Hoffmann La Roche Ltd
13.8 Biocon Ltd.
13.9 Genentech USA
13.10 Merck & Co., Inc.,
13.11 Teva Pharmaceutical Industries Ltd.
13.12 Varian Medical Systems, Inc.
13.13 Ethicon, Inc.
13.14 Hetero Drugs Ltd.

List of Tables
Table 1 Global Cervical Cancer Treatment Market By Region, Market Forecast (2015-2027) (US $MN)
Table 2 Global Cervical Cancer Treatment Market By Treatment, Market Forecast (2015-2027) (US $MN)
Table 3 Global Cervical Cancer Treatment Market By Chemotherapy, Market Forecast (2015-2027) (US $MN)
Table 4 Global Cervical Cancer Treatment Market By Carboplatin, Market Forecast (2015-2027) (US $MN)
Table 5 Global Cervical Cancer Treatment Market By Bevacizumab, Market Forecast (2015-2027) (US $MN)
Table 6 Global Cervical Cancer Treatment Market By Paclitaxel, Market Forecast (2015-2027) (US $MN)
Table 7 Global Cervical Cancer Treatment Market By Oxorubicin, Market Forecast (2015-2027) (US $MN)
Table 8 Global Cervical Cancer Treatment Market By Cisplatin, Market Forecast (2015-2027) (US $MN)
Table 9 Global Cervical Cancer Treatment Market By Other Chemotherapies, Market Forecast (2015-2027) (US $MN)
Table 10 Global Cervical Cancer Treatment Market By Hormone Therapy, Market Forecast (2015-2027) (US $MN)
Table 11 Global Cervical Cancer Treatment Market By Progesterone, Market Forecast (2015-2027) (US $MN)
Table 12 Global Cervical Cancer Treatment Market By Oestrogen, Market Forecast (2015-2027) (US $MN)
Table 13 Global Cervical Cancer Treatment Market By Testosterone, Market Forecast (2015-2027) (US $MN)
Table 14 Global Cervical Cancer Treatment Market By Progestogens, Market Forecast (2015-2027) (US $MN)
Table 15 Global Cervical Cancer Treatment Market By Radiation Therapy, Market Forecast (2015-2027) (US $MN)
Table 16 Global Cervical Cancer Treatment Market By Brachytherapy, Market Forecast (2015-2027) (US $MN)
Table 17 Global Cervical Cancer Treatment Market By External Beam Radiation, Market Forecast (2015-2027) (US $MN)
Table 18 Global Cervical Cancer Treatment Market By Surgery, Market Forecast (2015-2027) (US $MN)
Table 19 Global Cervical Cancer Treatment Market By Laser Surgery, Market Forecast (2015-2027) (US $MN)
Table 20 Global Cervical Cancer Treatment Market By Trachelectomy, Market Forecast (2015-2027) (US $MN)
Table 21 Global Cervical Cancer Treatment Market By Radical Hysterectomy, Market Forecast (2015-2027) (US $MN)
Table 22 Global Cervical Cancer Treatment Market By Cryosurgery, Market Forecast (2015-2027) (US $MN)
Table 23 Global Cervical Cancer Treatment Market By Simple Hysterectomy, Market Forecast (2015-2027) (US $MN)
Table 24 Global Cervical Cancer Treatment Market By Other Surgeries, Market Forecast (2015-2027) (US $MN)
Table 25 Global Cervical Cancer Treatment Market By Targeted Therapy, Market Forecast (2015-2027) (US $MN)
Table 26 Global Cervical Cancer Treatment Market By Pazopanib, Market Forecast (2015-2027) (US $MN)
Table 27 Global Cervical Cancer Treatment Market By Bevacizumab, Market Forecast (2015-2027) (US $MN)
Table 28 Global Cervical Cancer Treatment Market By Loop Electrosurgical Excision Procedure (LEEP), Market Forecast (2015-2027) (US $MN)
Table 29 Global Cervical Cancer Treatment Market By Cone Biopsy, Market Forecast (2015-2027) (US $MN)
Table 30 Global Cervical Cancer Treatment Market By Cold Knife Conization, Market Forecast (2015-2027) (US $MN)
Table 31 Global Cervical Cancer Treatment Market By Type, Market Forecast (2015-2027) (US $MN)
Table 32 Global Cervical Cancer Treatment Market By Adenosquamous Carcinomas, Market Forecast (2015-2027) (US $MN)
Table 33 Global Cervical Cancer Treatment Market By Squamous Cell Carcinomas, Market Forecast (2015-2027) (US $MN)
Table 34 Global Cervical Cancer Treatment Market By Adenocarcinomas, Market Forecast (2015-2027) (US $MN)
Table 35 Global Cervical Cancer Treatment Market By Material, Market Forecast (2015-2027) (US $MN)
Table 36 Global Cervical Cancer Treatment Market By Biologically Derived Materials, Market Forecast (2015-2027) (US $MN)
Table 37 Global Cervical Cancer Treatment Market By Synthetic Materials, Market Forecast (2015-2027) (US $MN)
Table 38 Global Cervical Cancer Treatment Market By Genetically Engineered Materials, Market Forecast (2015-2027) (US $MN)
Table 39 Global Cervical Cancer Treatment Market By Other Materials, Market Forecast (2015-2027) (US $MN)
Table 40 Global Cervical Cancer Treatment Market By Product, Market Forecast (2015-2027) (US $MN)
Table 41 Global Cervical Cancer Treatment Market By Treatment, Market Forecast (2015-2027) (US $MN)
Table 42 Global Cervical Cancer Treatment Market By Keytruda, Market Forecast (2015-2027) (US $MN)
Table 43 Global Cervical Cancer Treatment Market By Generics, Market Forecast (2015-2027) (US $MN)
Table 44 Global Cervical Cancer Treatment Market By Avastin, Market Forecast (2015-2027) (US $MN)
Table 45 Global Cervical Cancer Treatment Market By Other Treatments, Market Forecast (2015-2027) (US $MN)
Table 46 Global Cervical Cancer Treatment Market By Prevention, Market Forecast (2015-2027) (US $MN)
Table 47 Global Cervical Cancer Treatment Market By Cervarix, Market Forecast (2015-2027) (US $MN)
Table 48 Global Cervical Cancer Treatment Market By Gardasil/Gardasil 9, Market Forecast (2015-2027) (US $MN)
Table 49 Global Cervical Cancer Treatment Market By Disease Indication, Market Forecast (2015-2027) (US $MN)
Table 50 Global Cervical Cancer Treatment Market By Early Invasive Stage, Market Forecast (2015-2027) (US $MN)
Table 51 Global Cervical Cancer Treatment Market By Advanced Invasive Stage, Market Forecast (2015-2027) (US $MN)
Table 52 Global Cervical Cancer Treatment Market By Pre-malignant lesions, Market Forecast (2015-2027) (US $MN)
Table 53 Global Cervical Cancer Treatment Market By Distribution Channel, Market Forecast (2015-2027) (US $MN)
Table 54 Global Cervical Cancer Treatment Market By Online Pharmacies, Market Forecast (2015-2027) (US $MN)
Table 55 Global Cervical Cancer Treatment Market By Hospital Pharmacies, Market Forecast (2015-2027) (US $MN)
Table 56 Global Cervical Cancer Treatment Market By Retail Pharmacies, Market Forecast (2015-2027) (US $MN)
Table 57 Global Cervical Cancer Treatment Market By End User, Market Forecast (2015-2027) (US $MN)
Table 58 Global Cervical Cancer Treatment Market By Diagnostic Centers, Market Forecast (2015-2027) (US $MN)
Table 59 Global Cervical Cancer Treatment Market By Pharmacies, Market Forecast (2015-2027) (US $MN)
Table 60 Global Cervical Cancer Treatment Market By Cancer Palliative care clinics, Market Forecast (2015-2027) (US $MN)
Table 61 Global Cervical Cancer Treatment Market By Hospitals, Market Forecast (2015-2027) (US $MN)

Note: North America, Europe, Asia Pacific, Middle East, Latin America, and RoW tables are represented in above manner.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Novartis
  • Eli Lilly And Company
  • Allergan, Plc.
  • GlaxoSmithKline
  • Hoffmann La Roche Ltd
  • Biocon Ltd.
  • Genentech USA
  • Merck & Co., Inc.,
  • Teva Pharmaceutical Industries Ltd.
  • Varian Medical Systems, Inc.
  • Ethicon, Inc.
  • Hetero Drugs Ltd.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll